Healthcare - Biotechnology - NASDAQ - BM
$ 21.29
-2.38 %
$ 1.54 B
Market Cap
-177.42
P/E
Price Target
Average
70.66%
Revenue Forecast
Estimate
32.97%
EBIT
Estimate
69.48%
Net Income
Estimate
40.82%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Kiniksa Pharmaceuticals, Ltd.
Wall Street analysts predict an average 1-year price target for KNSA of $36.3 , with forecasts ranging from a low of $34 to a high of $40 .
KNSA Lowest Price Target
Wall Street Target
34 USD
59.70%
KNSA Average Price Target
Wall Street Target
36.3 USD
70.66%
KNSA Highest Price Target
Wall Street Target
40 USD
87.88%
REVENUE FORECAST
Revenue Forecast Chart KNSA
EBIT FORECAST
EBIT Forecast Chart KNSA
NET INCOME FORECAST
Net Income Chart KNSA